Aug 5, 2026 04:07PM
Apr 30, 2026 04:30PM
Apr 20, 2026 06:40AM
Apr 16, 2026 04:06PM
Apr 16, 2026 04:05PM
Mar 3, 2026 08:00AM
Mar 3, 2026 08:00AM Emergent BioSolutions Announces Appointment of John D. Fowler, Jr. to Board of Directors
Feb 26, 2026 04:05PM
Oct 29, 2025 04:15PM
Aug 27, 2025 08:01AM
Aug 6, 2025 04:15PM
May 7, 2025 04:05PM
Mar 3, 2025 04:23PM
Nov 6, 2024 04:05PM Emergent BioSolutions Reports Third Quarter 2024 Financial Results
Oct 2, 2024 07:33AM
Oct 2, 2024 07:30AM
Sep 3, 2024 07:09AM
Sep 3, 2024 07:08AM
Sep 3, 2024 07:08AM
May 15, 2023 07:58AM
Feb 15, 2023 02:00AM Emergent BioSolutions Announces Sale of Travel Health Business to Bavarian Nordic for Up To $380 Million
Feb 15, 2023 02:00AM
Aug 10, 2022 06:30AM
Aug 10, 2022 06:30AM
Aug 23, 2021 04:05PM
Aug 23, 2021 04:05PM
Aug 18, 2020 06:31AM
Aug 18, 2020 06:31AM Emergent BioSolutions to Participate in Virtual Investor Conferences
Jul 2, 2020 06:50AM
Sep 4, 2019 04:19AM
Aug 14, 2019 04:15PM
Aug 14, 2019 04:15PM
Dec 12, 2018 01:15PM
Oct 15, 2018 04:30PM
Oct 15, 2018 04:30PM Emergent BioSolutions Completes Acquisition of Adapt Pharma and Flagship Product Narcan® (Naloxone HCI) Nasal Spray
Aug 28, 2018 04:31PM
Aug 28, 2018 04:31PM
Aug 17, 2018 07:00AM
Aug 17, 2018 07:00AM
Apr 25, 2018 12:58AM
Mar 1, 2018 06:46AM
Nov 14, 2017 05:38PM Emergent BioSolutions Announces Notice of Termination of Conversion Rights of 2.875% Convertible Senior Notes Due 2021
Oct 2, 2017 07:00AM
Sep 27, 2017 12:54PM
Dec 29, 2016 04:15PM
Sep 30, 2016 10:33AM
Feb 19, 2016 08:33AM
Dec 21, 2015 04:15PM

84,215 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All